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Abstract
Background: The use of amphetamine-type stimulants (ATS) places a large burden on health services.
Objective: The aim was to evaluate the effectiveness of a self-guided Web-based intervention (“breakingtheice”) for ATS users
over 6 months via a free-to-access site.
Methods: We conducted a randomized trial comparing a waitlist control with a fully automated intervention containing 3
modules derived from cognitive behavioral therapy and motivation enhancement. The main outcome was self-reported ATS use
in the past 3 months assessed at 3- and 6-month follow-ups using the Alcohol, Smoking, and Substance Involvement Screening
Test (ASSIST). Secondary outcomes were help-seeking intentions (general help-seeking questionnaire), actual help seeking
(actual help-seeking questionnaire), psychological distress (Kessler 10), polydrug use (ASSIST), quality of life (European Health
Interview Survey), days out of role, and readiness to change. Follow-up data were evaluated using an intention-to-treat (ITT)
analysis with a group by time interaction.
Results: We randomized 160 people (intervention: n=81; control: n=79). At 6 months, 38 of 81 (47%) intervention and 41 of
79 (52%) control participants provided data. ATS scores significantly declined for both groups, but the interaction effect was not
significant. There were significant ITT time by group interactions for actual help seeking (rate ratio [RR] 2.16; d=0.45) and
help-seeking intentions (RR 1.17; d=0.32), with help seeking increasing for the intervention group and declining for the control
group. There were also significant interactions for days completely (RR 0.50) and partially (RR 0.74) out of role favoring the
intervention group. However, 37% (30/81) of the intervention group did not complete even 1 module.
Conclusions: This self-guided Web-based intervention encouraged help seeking associated with ATS use and reduced days out
of role, but it did not reduce ATS use. Thus, this program provides a means of engaging with some sections of a difficult-to-reach
group to encourage treatment, but a substantial minority remained disengaged.
Trial Registration: Australian and New Zealand Clinical Trials Registry: ACTRN12611000947909;
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=343307 (Archived by WebCite at
http://www.webcitation.org/6Y0PGGp8q).
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Introduction
Methamphetamine and other amphetamine-type stimulants
(ATS) increase the concentrations of monoamine
neurotransmitters in the synaptic cleft with associated feelings
of increased energy, confidence, and euphoria in the user [1].
It is estimated that between 14 and 52 million people used ATS
in 2010. This means that the prevalence of ATS use is second
only to cannabis of the illicit drugs [2]. ATS can be highly
addictive, particularly the more potent formulations (eg,
crystalline) and when used via more rapidly absorbed routes
(eg, smoking, injecting) [3]. The prevalence of dependence on
ATS and the harms resulting from ATS place a considerable
burden on health resources, especially in Asia and Oceania, but
also in Europe and North America [2,4].
In Australia, it is estimated that 97,000 people are dependent
on ATS but few specialist treatment services are available [5]:
data suggest that just 16% of nondependent and approximately
30% of dependent methamphetamine users received any
treatment for their drug use in the previous year [6,7]. With no
pharmacotherapy currently approved for ATS disorders,
treatment relies on face-to-face interventions, typically in the
form of cognitive behavioral therapy (CBT) or contingency
management, which can be extremely resource intensive,
preventing their widespread implementation [8,9].
Even where services exist, they are not always accessed by
clients. Overall, approximately 24% of those with a substance
use disorder used health services for a mental health problem
in the previous year, but service use by young people,
particularly young males, was much lower (13.2%) [10,11]. A
number of potential physical and psychological barriers have
been identified that could inhibit utilization of services,
including cost, stigma, lack of awareness, and poor access
[12,13]. Web-based interventions have the potential to extend
the reach of conventional interventions and could overcome
many of these impediments [14].
There has been considerable interest in the development and
evaluation of Web-based interventions for tobacco use or alcohol
consumption, with a recent systematic review summarizing data
from studies involving nearly 40,000 smokers [15] and a review
of online interventions for alcohol finding 16 studies comprising
more than 5600 participants [16]. However, the development
of Internet interventions for illicit drug use is at a more formative
stage. A meta-analysis of outcomes for computer- and
Web-based interventions for cannabis use reported on 10 studies
with a total of 4125 participants. Overall the effect size in
reducing consumption was small (g=0.16) [17]. Limited data
are available for Web- and computer-based interventions for
users of other illicit drugs, either targeting users of specific
drugs (eg, cocaine) [18] or multiple drugs [19-22]. The authors
are not aware of any other interventions specifically targeting
users of ATS, although we have previously reported outcomes
to 3 months [23].
The current study used a randomized design to evaluate the
effectiveness of a Web-delivered fully automated intervention
for users of ATS against a waitlist comparison group. It was
hypothesized that the intervention group would have a greater
reduction in their use of ATS 6 months after starting the
intervention than the control group. We also examined whether
the intervention resulted in improvements on a range of
secondary outcomes (detailed subsequently).
Methods
Design
To evaluate the intervention, we used a randomized controlled
trial with the intervention group receiving a fully automated,
3-module, Web-delivered intervention. Those in the waitlist
group underwent the same assessments as the intervention group,
but could not access the intervention for 6 months. Contact
details for emergency services were given to participants for
crisis support. We have previously described the methodology
in detail; the key features are described in the following
subsections [24].
Sample
We advertised for participants on social network sites and
posters in local clinics; all enrollment processes occurred
through the study website. To be eligible, participants had to
be resident in Australia, aged 18 years or older, and reported
use of ATS (eg, meth/amphetamine, ecstasy, nonmedical use
of prescription stimulants) in the previous 3 months. Because
of the nature of the intervention, participants were required to
have access to the Internet and to provide a valid email address.
We excluded potential participants if they reported that they
were currently receiving any treatment for stimulant
abuse/dependence or methadone, naltrexone, or buprenorphine
for a substance use disorder. Those who reported that a doctor
had ever diagnosed them as having schizophrenia,
schizoaffective, or bipolar disorder were also excluded. Finally,
we inspected registration details and 9 cases were excluded as
duplicate registrations (eg, identical IP addresses/payment
addresses.). Figure 1 provides details of the number recruited
and the flow of participants through the study to 6 months.
Recruitment ran from January to July 2013.
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Figure 1. CONSORT flow diagram for breakingtheice study.
Procedure
All participants were screened and enrolled via the free study
website. Those who fulfilled the eligibility criteria were invited
to provide consent by “clicking” an onscreen box for each
element of the consent form. After consent, the website
generated a personalized link that was sent to the participant’s
email address. This enabled the participants to create their own
study username and password. Next, participants were directed
to an online baseline survey. Finally, they were randomized
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using a fully automated system (1-to-1 allocation ratio and with
permuted blocks of 4). Participants who were not eligible for
the study were provided with information about other potentially
relevant websites and community resources.
The intervention group was provided with immediate access to
the first module. We recommended that 1 module should be
completed each week, but participants were able at advance at
their own pace. However, to progress through the program, each
page of a module had to be “opened” in sequence to finish that
module and progress to the next. Participants could return to
any page or module that had already been accessed. Participants
received a reminder email 3 days after the expected start date
if the first module had not commenced, with a further email
sent at day 7 when the next module was due. This pattern of
emails was repeated for the other modules. Participants were
sent further emails at 3 and 6 months inviting them to complete
the follow-up surveys. There was also opportunity at 6 months
to provide feedback on the intervention. Participants received
AU $20 for each baseline and follow-up assessment, with
payment by either posted or online vouchers. The Australian
National University Human Research Ethics committee
approved the study and it was registered with the Australian
and New Zealand Clinical Trials Registry (#12611000947909).
Measures
Outcome data were collected at 3 and 6 months and were all
self-reported. The study’s primary outcome measure was ATS
use assessed with the Alcohol, Smoking, and Substance
Involvement Screening Test (ASSIST) [25]. We also collected
secondary outcomes on (1) help-seeking intentions (General
Help-Seeking Questionnaire) [26], (2) actual help seeking
(Actual Help-Seeking Questionnaire) [27,28], (3) psychological
distress (Kessler Psychological Distress Scale [K-10]) [29], (4)
polydrug use measured by the ASSIST [25], (5) quality of life
(European Health Interview Survey Quality of Life scale
[EUROHIS]) [30], (6) days partial or wholly out of role [31],
and (7) readiness to change (Readiness to Change Questionnaire
[RTCQ]) [32]. Demographic details (eg, age, sex), history of
drug use (eg, age of first use of ATS), and severity of
dependence as measured by the Severity of Dependence Scale
(SDS) [33] were collected as part of the baseline survey. The
feedback survey included free-text fields plus the 16-item
Internet Intervention Adherence Questionnaire [34] and the
16-item Satisfaction with Service measure adapted from the
ANU Wellbeing study to reference ATS use rather than
depression [35].
Scoring and Coding
The ASSIST appraises lifetime and past 3-month use of 9 classes
of drugs (ie, tobacco, alcohol, cannabis, cocaine, ATS, inhalants,
sedatives, hallucinogens, opioids, and other). The standard
ASSIST scoring algorithm was used to calculate a score for
ATS use in the past 3 months, providing scores in the range
0-39 [25] (see Multimedia Appendix 1 for further information).
We assessed help-seeking intentions with the question: “How
likely is it that you would seek help from each of the following
people for any amphetamine or other drug use problems during
the next 4 weeks?” For each of 9 potential sources of help, there
was a 7-point scale (“extremely unlikely” to “extremely likely”)
with a score range between 9 and 63. The list did not include
breakingtheice. The actual help-seeking measure asked “Which
of the following people have you gone to for advice or help in
the past 2 weeks for any amphetamine or other drug use
problems?” It then listed the same 9 sources of help (range 0-9).
We used the total score on the K-10 to evaluate psychological
distress. The K-10 uses a 5-point scale (“none of the time” to
“all of the time”) with a score range between 10 and 50 [29].
To quantify the extent of polydrug use, we summed the ASSIST
classes of drugs, excluding ATS use [25]. The total score on
the EUROHIS (range 8-40) was used to assess quality of life:
higher scores indicate better outcomes [30]. We assessed days
completely and partially out of role (both range 0-30) in the
previous month using the wording from Kessler’s days out of
role measure, but referencing “ATS drug use” rather than
“depression” [31]. We modified the RTCQ to reference ATS
as opposed to alcohol consumption. The measure has 4 items
addressing the precontemplation, contemplation, and action
stages. Participants were allocated to their highest scoring stage
or, in the event of tied scores, to the higher stage [32].
Sample Size
We determined the sample size required to evaluate the primary
outcome (ATS score) at a power of 0.8 to detect a medium effect
size (eg, d=0.5) [36]. This required 60 people per group, but
allowing for 20% attrition, we recruited a total of 80 people per
group. The effect size was based on the development study for
the ASSIST in Australia [25] and a brief motivational
intervention for non-treatment-seeking users of ecstasy [37].
Modules
The content of the modules has been previously described [24].
We based the intervention on principles from motivational
interviewing (MI) and CBT and adapted from a face-to-face
intervention evaluated in amphetamine users [38]. We also
adapted the “decisional balance” approach [39] and asked
participants to list both the pros and cons of ATS consumption
and the potentially good and bad outcomes anticipated from
changing their use of ATS. To help participants change their
drug use, we assisted them in the development of skills and
strategies to aid in behavioral change (eg, identifying people
who could assist them, approaches to help in controlling urges
and overcoming cravings, refusal skills, and an action plan to
deal with high-risk situations). Example images from the
program are available in Multimedia Appendix 2.
Analysis
Initial analyses were conducted in SPSS v21 (IBM Corp,
Armonk, NY, USA). Descriptive analyses reported means with
standard deviations for continuous measures or percentages for
categorical outcomes together with their associated statistics (t
test or chi-square test). Effect sizes were calculated as (1)
difference in posttest minus pretest means for the 2 conditions
divided by their common pretest standard deviation, multiplied
by a bias correction factor (1–3/4[ntreatment+ncontrol-2]-1) [40]
and (2) as Cohen’s d (posttest intervention mean minus posttest
control mean divided by common standard deviation). The
characteristics of participants lost to follow-up at 6 months was
assessed with logistic regression using baseline predictors of
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condition, highest education level, age, age of first ATS use,
gender, SDS, K-10, ASSIST ATS, polydrug use, RTCQ
category, and actual and intended help-seeking scores.
The primary analysis used an intention-to-treat (ITT) approach
with the effect of the intervention on each outcome being
assessed using a time by group interaction. To analyze the
correlated data arising from the repeated measures we used a
multilevel mixed-effects regression model with a random
intercept term to control for clustering of variance on individuals
over repeated measures [41]. This analysis was conducted with
Stata SE version 11.2 (StataCorp LP, College Station, TX, USA)
using the xtmixed, xtmepoisson, and xtmelogit command suites
for linear, Poisson, and logit models, respectively. Measures of
days out of role, intended help seeking, and actual help seeking
were analyzed using a Poisson distribution. Readiness to change
was recoded as a binary variable reflecting action stage versus
contemplation or precontemplation stages and analyzed using
a logit model. All other outcomes were continuous and analyzed
using a linear model. For all measures, we used an unstructured
correlation matrix. At baseline, the groups differed significantly
on actual help seeking (see Results). To adjust for this
difference, baseline actual help seeking was included as a
covariate in all models (except for where actual help seeking
was the outcome). All models were adjusted for baseline SDS
score due to its importance in predicting attrition (see Results).
For the primary outcome (ATS score), we imputed missing data
using an iterative Markov chain Monte Carlo (MCMC) method
in SPSS to generate 25 sets of data. Maximum and minimum
values were logically constrained (eg, to the possible range of
scores on the ASSIST), with baseline outcomes and
demographic variables used as predictors. The imputed model
was conducted in SPSS using the equivalent multilevel
mixed-effects linear model to the unimputed model. We also
conducted a per-protocol analysis where the “group” variable
was replaced with a variable representing exposure to the
intervention (“completed any modules,” “completed no
modules,” or “control group”).
Results
The majority of participants were male (121/160, 75.6%), the
mean age was 22.4 (SD 6.3) years, and 18 of 160 (11.3%)
reported using ATS daily or almost daily. In addition, previous
treatment for ATS use was reported by 9.4% (15/160) of
participants (control: n=7; intervention: n=8) and 23 of 160
(14.4%) reported ever injecting drugs. Table 1 displays the
descriptive data at 6 months plus the effect sizes. Baseline
characteristics were similar on all measures except for actual
help seeking, in which the intervention group had significantly
lower levels than the control group (mean 0.3 vs 0.8).
(Multimedia Appendix 3 provides mean, SD, and n for each of
the outcome variables).
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Table 1. Descriptive characteristics by study group at baseline and 6 months plus effect sizes (change from baseline to 6 months on mean scores and
between groups at 6 months).














64 (79)57 (72)cSex (male), n (%)
22.2 (5.5)22.5 (7.1)Age (years), mean (SD)
17.7 (2.6)18.6 (4.2)Age first ATS use, mean (SD)
3.7 (3.5)3.8 (3.3)SDS, mean (SD)
ATS frequency in past 3 months, n (%)
5 (13)8 (20)——Never
14 (37)12 (29)20 (25)27 (34)1-2 times
9 (24)9 (22)33 (41)18 (23)Monthly
6 (16)10 (24)21 (26)23 (29)Weekly
4 (11)2 (5)7 (9)11 (14)Daily/almost daily
0.10d0.07d13.8 (9.6)12.8 (11.1)17.0 (10.1)16.8 (11.1)ATS score, mean (SD)
0.31e0.32e22.6 (12.3)19.4 (9.2)19.7 (11.2)20.4 (10.9)Intended help seeking, mean (SD)
—0.45e0.6 (0.9)0.6 (0.9)0.3 (0.7)f0.8 (1.3)fActual help seeking, mean (SD)
16 (42)15 (37)20 (25)34 (43)Any actual help seeking (yes), n (%)
0.10d0.12d22.9 (10.0)22.0 (8.7)22.2 (8.4)22.3 (8.3)K-10 score, mean (SD)
0.05d–0.06e4.5 (2.1)4.4 (1.9)4.8 (1.8)4.6 (1.6)Polydrug use, mean (SD)
0.19d0.05d27.3 (6.8)28.6 (6.8)27.2 (6.3)28.2 (5.8)Quality of life, mean (SD)
0.02e–0.12e2.8 (6.2)2.9 (5.8)3.5 (5.6)2.9 (5.9)Days out of role, mean (SD)
0.05d–0.04e3.3 (5.7)2.8 (4.5)3.9 (5.3)3.2 (4.8)Days partially out of role, mean (SD)
RTCQ, n (%)
13 (34)17 (42)27 (33)32 (41)Precontemplation
7 (18)9 (22)35 (43)24 (30)Contemplation
18 (47)15 (37)19 (24)23 (29)Action
a ATS: amphetamine-type stimulants; K-10: Kessler 10; quality of life: EUROHIS score; RTCQ: Readiness to Change Questionnaire; SDS: Severity
of dependence.
b Missing data at 6 months all outcome variables missing data n=81
c One person reported sex as “other”.
d Favors control group.
e Favors intervention group.
f Levene’s correction for inequality of variances (t113=2.83, P=.01).
Attrition and Engagement
At 6 months, 41 of 79 (52%) participants from the control and
38 of 81 (47%) from the intervention completed follow-up
surveys (Figure 1). Logistic regression showed that retention
was not significantly related to group allocation (OR 1.17, 95%
CI 0.56-2.47). However, females had higher odds of retention
(OR 3.11, 95% CI 1.28-7.55) as did older participants (OR 1.10,
95% CI 1.00-1.20) and those with greater psychological distress
(K-10 scores; OR 1.07, 95% CI 1.01-1.14). In addition, higher
baseline SDS scores reduced the odds of remaining in the study
(OR 0.73, 95% CI 0.59-0.91). In terms of “exposure to the
intervention” among the intervention group, 30 of 81 (37%)
people did not start or complete the first module, 6 of 81 (7%)
completed 1 module only, 6 of 81 (7%) completed 2 modules
only, and 39 of 81 (48%) completed all 3 modules. Those who
completed any modules (28/51) were not more likely to
complete the 6-month follow-up than those who completed zero
modules (10/30; χ21=3.5, P=.06).
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There was a significant main effect on ATS scores, with both
groups reducing use by 6 months (b=–2.59, SE 0.98; P=.008).
However, the interaction term was not significant, showing that
the intervention group did not improve more than the control
group (Table 2). The ITT analysis was based on those with
baseline data plus at least 1 follow-up. There was a significant
group by time interaction for actual help seeking (b=0.77, P=.02,
rate ratio [RR] 2.16, 95% CI 1.14-4.10) and for intended help
seeking (RR 1.17, 95% CI 1.05-1.31). There were also
significant group by time interactions for number of days out
of role (RR 0.50, 95% CI 0.37-0.68) and days partially out of
role (RR 0.74, 95% CI 0.56-0.98). In both instances, the
intervention group had a greater reduction in days of
“impairment” than the control group. Finally, a greater
proportion of those receiving breakingtheice transitioned to the
action stage than controls (OR 4.13, 95% CI 1.03-16.58). In the
analyses involving imputation, the overall group by time
interaction for ATS scores was not significant (F1,318=0.165,
P=.69) controlling for baseline SDS and baseline actual help
seeking.
Table 2. Statistics for group by time interactiona for intention-to-treat (ITT) analyses with unstandardized coefficient (b), standard error (SE), and P
values.
Group × 6 monthsGroup × 3 monthsGroup × 3 and 6 monthsVariableb
Pb (SE)Pb (SE)Pb (SE)
.650.87 (1.91).950.10 (1.67).850.27 (1.41)ATS score
<.0010.28 (0.07).870.01 (0.07).0050.16 (0.06)Intended help seeking
.020.90 (0.40).120.61 (0.39).020.77 (0.33)Actual help seeking
.640.81 (1.71).16–1.79 (1.26).90–0.16 (1.20)K-10 score
.68–0.16 (0.37).08–0.64 (0.36).23–0.37 (0.30)Polydrug use
.690.46 (1.15).430.75 (0.95).550.52 (0.85)Quality of life
<.001–0.72 (0.18)<.001–1.05 (0.24) p<.001–0.70 (0.16)Days out of role
.27–0.19 (0.17).003–0.53 (0.18).04–0.30 (0.14)Days partially out of role
.081.61 (0.93).171.04 (0.76).0451.42 (0.71)RTCQ
a Group by time interactions adjusted for actual help seeking at baseline and SDS score at baseline: reference group=control.
b ATS: amphetamine-type stimulants; K-10: Kessler 10; quality of life=EUROHIS score; RTCQ: action stage on the Readiness to Change Questionnaire.
Effect of Exposure
The “per-protocol” analyses found significant condition
(completed any modules, completed no modules, control group)
by time interactions for a number of variables for those who
completed any modules compared with controls. For actual help
seeking, the rate ratio was 3.13 (95% CI 1.43-6.84) and for
intended help seeking it was 1.31 (95% CI 1.16-1.48). Those
who completed any modules had significant reductions in both
days out of role (RR 0.46, 95% CI 0.33-0.63) and partial days
out of role (RR 0.57, 95% CI 0.41-0.77) compared with controls.
Those completing any modules were also more likely to
transition to the action stage than controls (OR 7.22, 95% CI
1.45-36.01). In one instance, there was a significant effect for
those who did not complete any modules compared with
controls—those taking no modules had an increase in days
partially out of role compared to controls (RR 1.56, 95% CI
1.00-2.42). It should be noted that a per-protocol analysis no
longer represents randomized data.
Feedback on the Intervention
Of the 81 people randomized to the intervention, 35 (43%)
provided feedback at 6 months. Free-text responses in particular
identified the use of fictional case stories as an engaging
approach. The main criticisms included the assumption that
people wanted to change their behavior and the lack of
information on benefits of drug use (eg, use of ATS to control
symptoms of attention deficit hyperactivity disorder). The most
frequently cited negative reactions to the intervention were
concerns about privacy (16/35, 46%) and boredom (7/35, 20%).
Most participants (22/35, 63%) reported that using the
intervention had reduced their adverse drug effects, 86% (30/35)
would recommend the site, 86% (30/35) endorsed Internet
delivery, 91% (32/35) rated the site as easy to use, and 91%
(32/35) were satisfied with the program.
Discussion
Principal Findings
The results of this study suggest that this fully automated
Web-based intervention may be useful both to increase help
seeking among people who use ATS and to augment their
intention to seek help in the future. There was also evidence for
a reduction in the number of days completely and partially out
of role. However, the intervention did not reduce ATS use
relative to a waitlist control group. Furthermore, relative to the
control group, there was no evidence that the intervention
reduced the use of other drugs, improved quality of life, or
reduced psychological distress.
We believe that breakingtheice is the first Web-based
intervention specifically targeting ATS users. However, its lack
of impact on ATS use is consistent with 2 previous Internet
interventions that included stimulant users. Snow Control
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targeted cocaine use [18] and found a decline in milligrams of
cocaine used per week at 6 months, but no significant effect of
the intervention over an attention control group. However, the
extremely high rate of attrition at 6 months (94%) makes
extrapolation from their findings difficult. A generic online
illicit drug (plus alcohol) screening and feedback program
developed in Sweden also reported high attrition by 6 months
with 69% lost to follow-up. Concordant with the current and
Snow Control studies, although drug use declined for both the
intervention and controls, there was no significant group by
time interaction at 6 months for drug use in the Swedish trial
[22].
In contrast, a recent Web-based intervention for cannabis use
derived from CBT and MI principles was successful in reducing
the frequency of cannabis use, but did not motivate participants
to seek additional professional help for their cannabis use, with
none of the experimental group seeking additional treatment by
3 months [42]. Although both the Rooke et al [42] and our study
involved illicit drug users and adapted treatments from the same
paradigms, the profiles of the participants differed with those
in the cannabis study being older (mean age 31 years), having
higher SDS (mean 14), and younger age of first use (mean 16
years). Further, the reduction in their cannabis use may mean
that they did not feel that extra help was required.
The mechanism by which the intervention resulted in fewer
days either partially or completely out of role is unclear given
that there was not a concomitant decrease in ATS scores or
improvements in quality of life or mental well-being. In our
sample at baseline, the days out of role equated to 35-42 days
per year, which is comparable with international data from
high-income countries for drug abuse (mean 37.8 days/year)
[43]. At 6 months, there was no change for the controls but the
intervention group had fallen to 33.6 days per year, an
improvement of more than 8 days per year. Subsequent research
is required to identify a plausible mechanism for this change.
Limitations
There are some limitations that should be considered in the
interpretation of these results. Firstly, the loss of participants
to follow-up threatens the validity and generalizability of
conclusions based on these data. However, the rate of attrition
(51%) is comparable with the average for fully automated
interventions (47%) [44], even though substance users would
be regarded typically as a group that is particularly difficult to
retain in research projects and treatment. Yet, some study
designs have improved follow-up, albeit with a different target
group. Interventions that have recruited mother-daughter dyads
to prevent cannabis use have achieved at least 90% retention at
12 months [17], but this method requires evaluation in other
groups. In addition to loss to follow-up, the fact that a substantial
minority in the intervention group did not complete even the
first module is of concern, although a low level of engagement
has also been identified as a difficulty in face-to-face
interventions [45,46]. This low level of engagement may have
contributed to the smaller that estimated effect size and the
consequent null results. However, the potential for widespread
dissemination means that even interventions with small effects
can have a public health impact [47].
The representativeness of our sample of ATS users, who were
required to have access to the Internet, compared with ATS
users in general could be questioned. However, at least in
Canada, it appears that users of cocaine or cannabis are as likely
to have access to the Internet as current drinkers [48] and the
Internet has been shown to be an effective means of reaching
hidden populations [49]. Nevertheless, it seems probable that
this approach will not reach the most severely disadvantaged
ATS users.
Although the feedback on the site was generally positive, we
note that these comments only represent a small proportion of
the intervention group: we would anticipate that those lost to
follow-up would be likely to have more negative opinions. We
did not correct for multiple statistical testing, in particular for
the secondary outcome measures (eg, all measures other than
the ATS score) and, thus, interpret our findings cautiously.
Nevertheless, we believe that the inclusion of a range of
secondary outcomes is warranted given that this is the first
intervention of this type with this population. With the caveat
that per-protocol analyses are biased, the per-protocol analyses
supports the interpretation that the changes in both help-seeking
measures, in days out of role, and transition to the action stage
on the RTCQ are not simply type 1 errors due to multiple
statistical testing. In each case, it was those who had been
exposed to the intervention that showed improvements, whereas
those who did not complete at least 1 module showed no
improvement compared with those in the control group.
We attempted to prevent duplicate registrations via inspection
of IP addresses and payment addresses. This approach does not
guarantee that duplicate registrations were eliminated with the
potential that dynamic IP addresses or multiple sites could be
used together with multiple email or physical addresses.
Implications
The finding that the intervention did not reduce ATS use per se
is unsurprising for several reasons. First, most of the intervention
focused on enhancing people’s motivation to reduce their ATS
use and seek help, with only the later modules focused on
strategies for reducing ATS use (module 3). Most of the
participants did not complete the last module. Second, the
intervention was designed to attract a broad range of ATS users,
but a desire to reduce or cease consumption of ATS was not a
requirement of the study. With respect to alcohol use, screening
and brief interventions in non-treatment-seeking groups have
been found to be effective [50]. The majority of participants in
this trial were using ATS at low levels (only 11% were using
daily or almost daily). Indeed, the feedback on the intervention
suggested that most people in the trial were not seeking to reduce
their ATS use with less than one-third in the action phase (see
Table 1) based on the RTCQ. This may explain why we failed
to reduce ATS use. Implementation of the intervention with
ATS users who had a greater need or desire for treatment would
be required before dismissing its potential to impact on ATS
use and related harms. Therefore, it may be necessary to further
develop aspects of the module that specifically aim to reduce
ATS use.
As noted previously, there was evidence of increased help
seeking associated with the intervention, albeit that this was
J Med Internet Res 2015 | vol. 17 | iss. 4 | e105 | p.8http://www.jmir.org/2015/4/e105/
(page number not for citation purposes)
Tait et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
predominantly with informal sources of help. Nevertheless,
outside the constraints of a research trial, any engagement with
the program could be used as an opportunity to provide
information and encouragement to seek further help, particularly
for those with low levels of interaction with the online program.
There is also the potential to evaluate the intervention as an
adjunct to conventional face-to-face treatment. Previous research
suggests that compared to a face-to-face CBT intervention alone,
online interventions designed to reduce illicit drug use can be
effective as an adjunct to weekly individual and group CBT
[51]. Integration with face-to-face services could also provide
the opportunity to allay privacy concerns expressed by some
participants. Furthermore, a Web-based program might allow
the extent of face-to-face treatment to be reduced and, hence,
lower the burden on service providers and clients inherent in
standard treatment.
Conclusions
There is strong evidence for the effectiveness of
technological-based programs such as Web- or
computer-delivered interventions for problematic use of alcohol
or tobacco use [52-55], but their impact on illicit drug use is
less certain [14,17]. Nevertheless, this study demonstrates that
is possible to engage some ATS users with a Web-based
program and retain many of them in a trial to 6 months, but a
substantial minority remained disengaged from the process and
the effect size across range of measures was small.
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